Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Seer Reports Third Quarter 2025 Financial Results
-
Alector Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 12, 2025
-
Nutanix Announces Date and Conference Call Information for First Quarter Fiscal Year 2026 Financial Results
-
Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer
-
SoundHound AI Reports Record Q3 Revenue of $42 Million, Up 68%, Raises Full Year Outlook; $269 Million in Cash
-
Texas Roadhouse, Inc. Announces Third Quarter 2025 Results
-
OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update
-
Dorchester Minerals, L.P. Announces Third Quarter Results
-
Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress
-
Clearmind Medicine Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
-
BLINK CHARGING ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS
-
WillScot Declares Quarterly Cash Dividend
-
Clearmind Medicine Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
-
Sunrun Announces Appointment of Craig Cornelius to its Board of Directors
-
Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
-
aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update
-
Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
-
Biofrontera Inc. to Report Third Quarter 2025 Financial Results on November 12, 2025 and Host a Conference Call on November 13, 2025
-
Progyny, Inc. Announces Third Quarter 2025 Results
-
Pacira BioSciences Reports Third Quarter 2025 Financial Results; Increases Full-year Gross Margin Guidance
-
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
-
Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
-
Peloton Announces Q1 2026 Financial Results, Raises Full Year 2026 Adjusted EBITDA Guidance
-
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance
-
Teknova Reports Third Quarter 2025 Financial Results
-
Sunrun Reports Third Quarter 2025 Financial Results
-
Astec Industries, Inc. (NASDAQ: ASTE) to Participate in Baird 2025 Global Industrial Conference on November 13, 2025
-
USA Rare Earth Reports Third Quarter 2025 Financial Results
-
Turtle Beach Corporation Announces Third Quarter 2025 Financial Results and Reiterates Full Year Guidance
-
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025
-
GigaCloud Technology Inc Announces Third Quarter and Nine Months Ended September 30, 2025 Financial Results
-
Research Frontiers Reports Third Quarter 2025 Financial Results and Will Host a Conference Call at 4:30p.m. Today
-
MidCap Financial Investment Corporation Reports Financial Results for the Quarter Ended September 30, 2025
-
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
-
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
-
Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates
-
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Bimini Capital Management Announces Third Quarter 2025 Results
-
IPG Photonics Expands Operations to Huntsville Alabama, Bringing Innovation to the Defense Industry
-
ChargeUp Accelerator for Battery Startups Opens Application Period for Cohort 3
-
FDCTech, Inc. Completes Acquisition of Alchemy International Ltd., a Licensed Securities Dealer in Seychelles
-
IREN Reports Q1 FY26 Results
-
BMO Insurance and Trupanion Join Forces to Bring Simple, Trusted Pet Insurance to More Canadians
-
Denali Therapeutics Announces Board and Executive Leadership Updates
-
U.S. Global Investors Announces Q1 Fiscal Year 2026 Webcast
-
ORIC® Pharmaceuticals Announces Publication in Cancer Research on the Discovery and Development of Enozertinib, a Highly Selective, Brain-Penetrant EGFR Inhibitor
-
Combined General Meeting of November 27, 2025 - Availability of the preparatory documents
-
Statement of total voting rights and shares forming the company’s share capital as October 20, 2025
-
WWIA and Hot Tubs of Tennessee Celebrate a Decade of Bringing Honor, Connection, and Healing to America’s Combat-Wounded Veterans

